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Background: Duchenne Muscular Dystrophy (DMD) is one of the most 
common lethal X-linked recessive genetic muscle disorders. It is caused 
by various mutations in the dystrophin gene. Due to the lack of efficient 
rehabilitation and treatment, prenatal diagnosis and proper genetic counseling 
of families with DMD are of great importance.  
aim of the Work: This study aimed to evaluate an Egyptian prenatal molecular 
experience considering the impact of molecular information, the availability 
of prenatal diagnosis, and the changing attitude and choices of the Egyptian 
families with DMD.  
Patients and Methods: The study characterized the deletion patterns in 85 
Egyptian patients with DMD and 32 fetuses from 27 mothers with previous 
history of DMD deletion mutations. Multiplex PCR amplification of 18 
exons covering the two hotspots within the dystrophin gene was pursued to 
detect deletions in the probands. Detection of deletions in the fetal DNA was 
performed by using the targeted multiplex containing the deleted exons.  
results: Forty-six out of eighty-five probands (55%) had deletion mutations. 
Twenty-four out of the forty-six (52%) probands had multiple exons deletion 
and twenty-two (48%) showed single exon deletion. Out of the thirty-two 
amniotic fetal samples, fourteen fetuses inherited the same deletions present in 
the index cases while eighteen were normal. An emerging awareness of genetic 
information was observed and an apparent higher number of mothers seeking 
prenatal diagnosis was noticed. A change of attitude in favor of choosing the 
decision of abortion was apparent. 
conclusion: Molecular diagnosis is an important tool for preventive medicine. 
It has an obvious impact on prenatal diagnosis and accurate genetic counseling. 
It also seems to have an impact on the attitude and choices of families in 
particular and society in general.
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introDuction                                                               
Duchenne Muscular Dystrophy (DMD) 
is one of the most common lethal X-
linked recessive genetic muscle disor-
ders with an incidence of approximate-
ly 1/3500 male live births.1 The affected 
patient is almost always a boy present-
ing with proximal muscle weakness be-
fore the age of five years, accompanied 
by remarkably elevated serum Creatine 
Kinase (CK) enzyme levels, myopathic 
changes on electromyography and re-
duced or absent expression of dystro-
phin in muscle histochemical prepara-
tions. Half of patients fail to walk at the 
age of 18 months, and others are con-
fined to a wheelchair at 7-11 years of 
age. DMD is a severely handicapping 
disease with relatively rapid progres-
sion. Death due to respiratory failure 
occurs by the end of the second decades 
of life.2
DMD is caused by mutations within the 
dystrophin gene. The dystrophin gene is 
a large gene (2.4 Mb), located at Xp21 
and comprises 79 exons. It codes for the 
dystrophin protein.3 Deletions, duplica-
tions and point mutations have been 
reported in most exons of the gene, es-
pecially the two hot-spot regions.4 One 
third of mutations are de novo.5 Con-
ventional molecular diagnosis of DMD 
is carried out by using multiplex PCR 
amplifications of the two major and 
minor hot spots within the dystrophin 
gene. Recently, a new technique, the 
multiplex ligation probe amplification 
(MLPA) has been described.6,7 MLPA is 
an accurate and sensitive technique in 
the detection of DMD rearrangements 
including deletions and duplications.8,9
A previous Egyptian molecular study re-
vealed that the most common deletions 
were within the two main hotspots with 
a 55% deletion frequency.10 This study 
reports the molecular diagnosis data 85 
probands and prenatal diagnosis data of 
27 mothers with a previous history of 
DMD deletion mutations. The molecu-
lar diagnosis has facilitated the provi-
sion of proper prenatal diagnosis based 
on mutational genetic data for families, 
thus opening the door for decision mak-
ing and counseling of Egyptian families 
with DMD. An interesting change in the 
acceptability and attitude of the coun-
seled families considering the social 
values and religious background was 
observed.
PatientS anD MethoDS                              
Subjects
Between the period of 2004 and 2007 
eighty five unrelated patients were re-
ferred to the Medical Molecular Genet-
ic Department at the National Research 
Center for detection of the dystrophin 
gene deletion mutations. Patients were 
diagnosed to have DMD based on clini-
cal findings, electromyography (EMG) 
and elevated serum Creatine Kinase 
activity. During this period thirty two 
fetuses delivered from twenty seven 
mothers were analyzed. One mother 
seeked prenatal diagnosis 3 times and 
another three requested it twice. Moth-
ers received genetic counseling entail-
ing family history and complete diag-
nostic data of the probands and prenatal 
counseling regarding ultrasound guided 
amniocentesis and its risks. Between 
14-18 weeks pregnancy 25ml amni-
otic fluid was obtained for fetal DNA 
extraction. The acceptability, response 
and attitudes of mothers were recorded 




Methods                                                    
Genomic and fetal DNA was extracted 
from blood and amniotic fluid respec-
tively using QIAamp®  DNA  Mini 
Kit (QIAGEN, Germany). Detection 
of deletions in the probands was car-
ried out by multiplex PCR (mPCR) us-
ing 18 exons in six multiplex reactions 
according to the modified technique of 
Chaimberlain and Biggs.10 Detection of 
deletions in the fetal DNA was pursued 
using mPCR amplification containing 
both the targeted deleted exons and non 
deleted exons as internal control. 
reSultS                                                              
Molecular analysis of probands
A total number of 85 probands revealed 
that 46 (55%) have deletion mutations. 
Twenty-four out of the forty-six (52%) 
probands had 13 multiple exons dele-
tion while twenty-two (48%) showed 
8 different single exon deletion (Table 
1). The most common single exon dele-
tion was exon 48 (10.8%) and the most 
common multiple exons deletion was 
45-52 (10.8%).
Molecular results of prenatal diagno-
sis
Thirty two fetuses delivered from 
twenty seven mothers were analyzed. 
Fourteen fetuses inherited the same de-
letions present in the index cases while 
eighteen were normal. Deletions de-
tected in the fetal DNA: [(1) del 8-12, 
(2) del 45, (2) del 45-52, (1) del 47-50, 
(1) del 51-52, (2) del 47, (1) del 4-6, 
(1) del 45-48,(1) del 19, (1) del 43, (1) 
del 48]. Postnatal samples were avail-
able from 10 out of the 18 fetuses with 
normal out come proving the reliability 
of the test. 
acceptability and attitude
The 27 mothers received the counseling 
eagerly and did not hesitate to pursue 
amniocentesis and obtain prenatal diag-
nosis. A notable increase in the number 
of mothers seeking amniocentesis in 
the last year was observed. All mothers 
with affected fetuses responded to the 
molecular results and did not hesitate to 
terminate pregnancy once informed that 
their fetuses were affected. 
DiScuSSion                                                 
Genetic counseling and prenatal diag-
nosis is a blooming field in obstetrics. 
This unique medical specialty provides 
clinical health care, education, and 
table 1: Different types and frequencies 






Exon 19 2 4.3%
Exon 43 2 4.3%
Exon 45 4 8.6%
Exon 47 3 6.5%
Exon 48 5 10.8%
Exon 50 1 2.1%
Exon 51 4 8.6%
Exon 52 1 2.1%
Exons 3-19 1 2.1%
Exons 4-6 1 2.1%
Exons 8-12 3 6.5%
Exons 8-13 1 2.1%
Exons 43-51 1 2.1%
Exons 45-48 2 4.3%
Exons 45-50 2 4.3%
Exons 45-52 5 10.8%
Exons 47-50 2 4.3%
Exons 48-50 2 4.3%
Exons 48-51 1 2.1%
Exons 48-52 1 2.1%
Exons 51-52 2 4.3%
108
The impact of prenatal diagnosis in Egyptian families with DMD.
emotional support to individuals and 
families facing genetic and inherited 
diseases11. Prenatal diagnosis depends 
on accurate molecular techniques, 
which have become simpler and more 
accurate, so transfer of technology is no 
more a barrier.12
The implementation of prenatal  diag-
nosis of DMD was based on the  iden-
tification of the molecular make up  of 
DMD in Egyptian patients. The data was 
collected from a prior study comprising 
165 Egyptian patients with DMD and 
the current study. Both studies revealed 
that the most common deletions were 
within the two main hotspots.10 Table 
(1) illustrates the breakdown pattern of 
deletion frequencies found in families 
with deletions (55%). The compilation 
of the breakdown of the different fre-
quencies of deletions of DMD in dif-
ferent countries is still an ongoing issue 
in attempt of completing the molecular 
deletion patterns and gaining a deeper 
understanding of exon deletion distri-
bution of DMD worldwide.13,14
In this study eight single exons deletion 
(19, 43, 45, 47, 48, 50, 51, 52) were 
found, the most common was exon 48; 
thirteen multiple exon deletions, the 
most was common 45-52. Identifying 
the breakdown pattern helped the de-
velopment of a molecular guideline for 
targeting and screening the most com-
mon deletions in our population thus 
saving time effort and expense. Also 
identifying the different mutations in 
these Egyptian studies encouraged the 
initiation of the prenatal molecular di-
agnosis clinic, which turned into one 
of the first specialized referral centers 
reflecting a true molecular prenatal ex-
perience in Egypt. The use of multiplex 
PCR was sufficient in this study for the 
provision of molecular diagnosis (Refer 
for details to prenatal results), although 
in families with no deletion mutations 
indirect analysis of CA repeats and 
polymorphic restriction sites are need-
ed for completeness.15,16,17 Confirmation 
of the accuracy of the prenatal molecu-
lar data was compared with the results 
postnatal, finding no discrepancies. 
This accuracy of molecular work up 
encouraged the determination of pursu-
ing successful counseling of mothers in 
Egypt. A notable increase in the number 
of mothers seeking amniocentesis dur-
ing the last three years was observed. 
An Egyptian study indicated that the 
leading cause for seeking amniocen-
tesis was a previous history with a ge-
netic disease.18 Not only the increasing 
number of mothers but also the repeated 
seeking of the same mother in repeated 
pregnancies indicated the high accept-
ability of mothers in seeking prenatal 
diagnosis.
Identifying the molecular defect in 
the fetus, whether affected or not, is a 
major concern for the Egyptian moth-
ers. Knowing that they are conceiving 
an affected child, they considered the 
decision of terminating rather than en-
dure the pain of watching the affected 
offspring deteriorate. In the past, moth-
ers seemed hesitant in pursuing the op-
tion of abortion as their first decision. 
It was a difficult step to pursue, due to 
lack of molecular diagnosis and proper 
genetic counseling. In addition, no clear 
religious and social support was avail-
able. Although seeking termination is 
a touchy subject, it is a serious choice 
to consider. In this study mothers with 
affected fetuses considered immediate 
termination, as they became aware of 
the option of different choices and that 
they could choose to live without the 
109
Effat et al.
burdens of raising a child with severe 
handicapping abilities. So an obvious 
new concept of acceptance and con-
fronting choices was observed. The at-
titude of mothers and society has shown 
a change regarding the active choice of 
abortion rather than the passive choice 
of leaving matters to fate. This change 
might be due to the exposure of continu-
ous new molecular genetic information. 
Time will unfold the depth of impact of 
this molecular information especially 
when recommendations of religious 
scholars reevaluate the terms of abor-
tion, considering the available molecu-
lar data. No doubt, prenatal diagnosis 
has become an important tool for pre-
ventive medicine and genetic counsel-
ing. Molecular prenatal diagnosis pro-
vides accurate data for proper genetic 
counseling and psychological support 
especially for anxious pregnant women 
with a history of a particular genetic 
disease. It also has an apparent impact 
on awareness, attitudes and choices of 
families with genetic disorders in par-
ticular and society in general. 
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